251 related articles for article (PubMed ID: 3255656)
1. [Pollen-induced allergy. Programming and monitoring of specific immunotherapy].
Obtułowicz K
Folia Med Cracov; 1988; 29(1-2):21-48. PubMed ID: 3255656
[No Abstract] [Full Text] [Related]
2. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
Ariano R; Panzani RC; Mistrello G
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of the effectiveness of 2 methods of specific immunotherapy of pollinoses].
Polsacheva OV; Gushchin IS; Poroshina IuA; Chitaeva VG; Shustova VI
Ter Arkh; 1986; 58(4):120-3. PubMed ID: 2424113
[No Abstract] [Full Text] [Related]
4. High-dose sublingual immunotherapy in children at 8-year follow-up.
Leonardi S; Spicuzza L; La Rosa M
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):259-60. PubMed ID: 19354077
[No Abstract] [Full Text] [Related]
5. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
6. Rush immunotherapy with sublingual administration of grass allergen extract.
Feliziani V; Marfisi RM; Parmiani S
Allergol Immunopathol (Madr); 1993; 21(5):173-8. PubMed ID: 8160561
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
Hordijk GJ; Antvelink JB; Luwema RA
Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
[TBL] [Abstract][Full Text] [Related]
8. Specific immunotherapy stimulates the binding of histamine H2 receptor antagonist by lymphocytes.
Zak-Nejmark T; Małolepszy J; Nadobna G; Kuczyńska-Sekieta K; Marczyńska-Sarul E; Jutel M
Arch Immunol Ther Exp (Warsz); 1992; 40(2):113-6. PubMed ID: 1299167
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.
Worm M
Eur Ann Allergy Clin Immunol; 2006 Dec; 38(10):355-60. PubMed ID: 17274520
[TBL] [Abstract][Full Text] [Related]
10. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
12. [Pollen monitoring, allergy and specific immunotherapy].
Varricchio A
Clin Ter; 1986 Jul; 118(1):3-8. PubMed ID: 3742973
[No Abstract] [Full Text] [Related]
13. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
Rak S; Heinrich C; Scheynius A
Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
[TBL] [Abstract][Full Text] [Related]
14. Sublingual immunotherapy.
Corrigan C
J Allergy Clin Immunol; 2007 Feb; 119(2):515; author reply 515-7. PubMed ID: 17187850
[No Abstract] [Full Text] [Related]
15. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
[TBL] [Abstract][Full Text] [Related]
16. [Monitoring specific immunotherapy using the 3M Diagnostic Systems reagent kits].
Szymański W; Chyrek-Borowska S
Pneumonol Alergol Pol; 1991; 59 Suppl 1():23-30. PubMed ID: 1843805
[No Abstract] [Full Text] [Related]
17. Rush sublingual immunotherapy in Parietaria allergic patients.
D'Ambrosio FP; Ricciardi L; Isola S; Savi E; Parmiani S; Puccinelli P; Musarra A
Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
[TBL] [Abstract][Full Text] [Related]
18. [How and when is immunotherapy for pollen allergy carried out?].
Kersten W
Med Klin; 1980 Oct; 75(21):751-4. PubMed ID: 7453622
[TBL] [Abstract][Full Text] [Related]
19. Sublingual immunotherapy: focus on tablets.
Passalacqua G; Canonica GW
Ann Allergy Asthma Immunol; 2015 Jul; 115(1):4-9. PubMed ID: 26123419
[No Abstract] [Full Text] [Related]
20. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
Werfel T
J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
